Debunking Section 174 Amortization Myths: Avoid R&D Tax Pitfalls

Introduction:

If you're wondering about "OBBBA Section 174 repeal details,""R&D tax credit myths 2025," or "how to claim retroactive R&D expensing," you've come to the right place. We'll break down the facts, debunk the top misconceptions, and arm you with actionable steps to maximize these benefits for your business.

Section 174 directly impacts how R&D expenses reduce your taxable income, but it is separate from the credit itself. For a complete overview, see our R&D Tax Credit guide.

Myth 1: Every Business Can Retroactively Amend Returns for 2022 to 2024 and Get Instant Refunds

You've probably seen posts claiming OBBBA lets anyone rewind the clock on past taxes. It's anappealing idea, but it's not that simple.

The Reality: Relief via retroactive cash refunds from amending returns (for 2022 to2024) is limited to small businesses meeting the $31 million annual gross receipts threshold (averaged over three years). If you're over $31M in average annual gross receipts, you can't amend prior years but can accelerate those unamortized deductions starting in 2025. Learn how to calculate your company' saverage annual gross receipts to see if it meets the requirements for retroactive expensing. Pending IRS guidance may clarify if unfiled 2024 return scan incorporate the election without amending, so consult a pro to avoid missteps and maximize refunds.

Pro Tip: If eligible, act before the July 6, 2026, deadline to elect this. It could mean real cash back for reinvesting in your team or tech.

Myth 2: OBBBA Wipes Out Amortization for All R&D Expenses, Including Foreign and Software Dev

Many assume the repeal is a blanket fix, covering everything from overseas projects to custom software builds in the US.

The Reality: Only domestic R&E gets immediate expense treatment under new Section 174A, so foreign costs are still required to be amortized over 15 years. Software development qualifies as R&E, but you'll need to prorate based on where the work happens (for example, U.S. coders count as domestic). This setup encourages keeping innovation stateside, though it doesn't erase all offshoring edges. For global teams, precise allocation is key to unlocking full benefits.

Myth 3: R&D Tax Credits Are Just for Big Tech Giants or Revolutionary Breakthroughs

This old misconception lingers, making many overlook credits that could slash their tax bill.

The Reality: Section 41 credits are open to businesses of all sizes innovating in everyday ways, like refining processes, building prototypes, or tweaking software, as long as they pass the four-part test(technological nature, discovery, experimentation, business purpose). The OBBBA makes them even more attractive by syncing with full expensing for R&D costs, and startups can apply up to $500,000 against payroll taxes if under five years old and below $5 million in annual receipts.

Myth 4: Filing for These Credits or Deductions Post-OBBBA Guarantees an IRS Examination

Examination fears, commonly called audit fears, are everywhere online, but they're often overblown.

The Reality: Claims don't automatically trigger R&D credit examinations(corporate examination rates hover around 0.9%), but solid documentation, like time logs, payroll records, project notes, and invoices, goes a long way to reduce any risk. OBBBA streamlines things with better Section 280C coordination, and compliant filers are having success. Focus on reasonable substantiation, not perfection. Bringing in experts for a study can make your case ironclad.

Note that this kind of examination is not a full-blown review of corporate tax returns and deductions, but simply a review of a company's R&D tax credit filing. All Strike Tax clients receive unlimited examination support services when they choose Strike to handle their R&D tax credit study and filings, so in the rare event of an examination, there are no additional headaches or fees.

State conformity to Section 174 varies widely, and some states still allow immediate expensing. Compare how federal and state R&D tax credits interact and where you can stack savings.

Myth 5: OBBBA Won't Really Fix Offshoring or Spark a Hiring Boom in Tech and Manufacturing

Skeptics say it's too little, too late for reversing trends like layoffs or moving R&D abroad.

The Reality: By eliminating the domestic amortization penalty, OBBBA levels the playing field, making U.S.-based innovation more tax-efficient and potentially boosting domestic hiring as cash flows improve, with experts forecasting rebounds by 2026. That said, results hinge on broader market factors. It's a strong incentive, not a silver bullet.

Myth 6: You Need Mountains of Paperwork to Qualify, or You're Out of Luck

The idea of "exhaustive documentation" scares off plenty of eligible businesses.

The Reality: While records are crucial for backing claims, there's no one-size-fits-all checklist. Project emails, payroll data, and note soften do the trick if they show your R&D efforts. OBBBA eases the burden by ending amortization tracking, making it simpler for all companies.

Myth 7: You Can Claim the Full R&D Credit and Deduction Without Any Trade-Offs Under Section 280C

"Double dipping" sounds great, but it's a common trap.

The Reality: Section 280C prevents over-benefiting. Claim the full credit, and you reduce your R&D deduction by that amount, or elect a reduced credit(usually 65%) to keep the full deduction. OBBBA doesn't change this but makes coordination smoother with expensing restored. Weigh your options based on your tax position for the best savings.

Ready to Capitalize on OBBBA? Let Strike Tax Advisory Guide You

Don't miss out on these opportunities to supercharge your innovation and bottom line—myths aside, OBBBA is built for businesses like yours. Reach out for a no-obligation chat; we'll review your eligibility, handle amendments, and optimize your R&D strategy. For more information, read our latest blog on 174 Amortization Repeal.

Official Resources